Quinone derivative 2,3-dimethoxy-5methyl6-(10-hydroxydecyl)-1,4-benzoquinone for the treatment of respiratory illness in muscular dystrophy

Details for Australian Patent Application No. 2009235681 (hide)

Owner Santhera Pharmaceuticals (Schweiz) AG

Inventors Meier, Thomas; Buyse, Gunnar

Agent Shelston IP

Pub. Number AU-B-2009235681

PCT Pub. Number WO2009/124693

Priority 08007069.1 09.04.08 EP; 61/043,480 09.04.08 US

Filing date 3 April 2009

Wipo publication date 15 October 2009

Acceptance publication date 5 April 2012

International Classifications

A61K 31/122 (2006.01) - having the oxygen atom directly attached to a ring, e.g. quinones, vitamin K, anthralin

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

21 October 2010 PCT application entered the National Phase

  PCT publication WO2009/124693 Priority application(s): WO2009/124693

5 April 2012 Application Accepted

  Published as AU-B-2009235681

2 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009235695-Combinations of biological control agents and insecticides or fungicides

2009235668-Ground peg, and device and method for the production thereof